Cargando…
Evidence of the Prognostic Value of Pretreatment Systemic Inflammation Response Index in Cancer Patients: A Pooled Analysis of 19 Cohort Studies
OBJECTIVE: Systemic inflammation response index (SIRI) is a new inflammation-based evaluation system that has been reported for predicting survival in multiple tumors, but the prognostic significance of SIRI in cancers has not been evinced. METHODS: Eligible studies updated on December 31, 2019, wer...
Autores principales: | Zhang, Yi, Liu, Fangteng, Wang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479458/ https://www.ncbi.nlm.nih.gov/pubmed/32934755 http://dx.doi.org/10.1155/2020/8854267 |
Ejemplares similares
-
Prognostic Value of the Pretreatment Systemic Immune-Inflammation Index in Patients with Colorectal Cancer
por: Li, Jing, et al.
Publicado: (2020) -
Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis
por: Qiu, Ye, et al.
Publicado: (2021) -
The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients
por: Jin, Bao, et al.
Publicado: (2021) -
Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis
por: Meng, Linghao, et al.
Publicado: (2023) -
Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
por: Chen, Li, et al.
Publicado: (2020)